Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 347

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1A
Chunk 347
---
 our operations, many of which have already manifested and are likely to increase, given recent executive action
in the United States.

We and currently all of our subsidiaries and investments conduct operations
outside of the United States, so that we are subject to the special considerations or risks associated with companies operating in
the United States and in an international setting, including any of the following:

●higher costs and difficulties inherent in managing cross-border business
operations and complying with different commercial and legal requirements of overseas markets;

●rules and regulations regarding currency exchange;

●complex corporate withholding taxes on individuals;

●laws governing the manner in which future business combinations
may be effected;

●tariffs and trade barriers;

●regulations related to customs and import/export matters;

●longer payment cycles and challenges in collecting accounts
receivable;

●tax issues, including but not limited to tax law changes and
variations in tax;

●currency fluctuations and exchange controls;

●rates of inflation;

●cultural and language differences;

●employment regulations;

●trade restrictions including limitations on imports or exports
of components or assembled products, unilaterally or bilaterally;

●trade sanctions and related regulatory enforcement actions and
other proceedings;

●potential trade wars;

●increased scrutiny by the media and other third parties of labor
practices within our industry (including but not limited to working conditions) which may result in allegations of violations, more stringent
and burdensome labor laws and regulations and inconsistency in the enforcement and interpretation of such laws and regulations, higher
labor costs, and/or loss of revenues if our customers become dissatisfied with our labor practices and diminish or terminate their relationship
with us;

●imposition of restrictions on currency conversion or the transfer
of funds;

●expropriation of private entities;

●ineffective legal protection of our intellectual property rights
in certain countries;

●crime, strikes, riots, civil disturbances, terrorist attacks,
natural disasters and wars;

●deterioration of political relations with the United States;
and

●government appropriations of assets.

We may not be able to adequately address these additional risks. If
we were unable to do so, our operations might suffer, which may adversely impact our results of operations and financial condition. Many
of the foregoing risks have already manifested, and are likely to increase in scope and impact in light of the recent public posture
and executive action of the new presidential administration in the United States.

57

Even if we obtain FDA approval of any of our product candidates,
we